ADVANCED MOLECULAR VISION LIMITED

Company number 05756054 ·

Active - Proposal to Strike off

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: ADVANCED MOLECULAR VISION LIMITED

1. Financial Health Score: F (Terminal)

Explanation: The company is not suffering from a curable illness; it is in the terminal stages of its corporate lifecycle. The patient has a "Do Not Resuscitate" order in the form of an active "Proposal to Strike off" status at Companies House, meaning the director has applied to voluntarily dissolve the business. Furthermore, the financial data reveals severe atrophy, with the company's asset base wasting away by over 98% from its 2020 peak. The business is no longer a going concern.

2. Key Vital Signs

  • Pulse (Company Status): Fading. The company is currently listed as "Active - Proposal to Strike off." This is the corporate equivalent of hospice care; the director has decided to end the company's life rather than continue trading.
  • Body Mass (Total Assets): Severe Wasting. Total assets have plummeted from £266,832 in 2020 to just £3,557 in 2025. The business has shed virtually all of its financial mass, indicating a complete wind-down of operations and asset realization.
  • Blood Pressure (Liquidity): Dangerously Low. Current assets sit at a mere £2,885 against current liabilities of £2,773. The current ratio is roughly 1.04:1. While technically solvent, the company has virtually no working capital pulse to sustain any operational heartbeat.
  • Immune System (Shareholders' Funds/Equity): Compromised. Net assets have dropped from £91,415 in 2018 to just £784 today. The company has almost zero financial resilience or buffer against unexpected claims.
  • Cholesterol (Liabilities): Clearing. Total liabilities have dropped from £231,854 in 2020 to £2,773 today. The company has successfully paid down or written off its debts, which is typical for a business in the final stages of winding up its affairs.

3. Diagnosis

The patient is suffering from Corporate Atrophy complicated by a Voluntary Termination.

Looking at the medical history, the business was relatively healthy between 2015 and 2020, maintaining assets between £100k and £260k. However, from 2021 onward, the business experienced a massive hemorrhage of value. The latest filed accounts confirm that the company has no stated principal activity, and the balance sheet has been reduced to a minimal shell.

The fact that the director, Mr. Ardeshir Arjomandi, has filed for a strike-off confirms that this is not a temporary coma; it is an intentional cessation of life. The business has been stripped down to almost nothing, with only £672 in fixed assets and £2,885 in current assets remaining. The lack of an audit and the preparation of accounts under the "micro-entity" provisions further illustrate how small and inactive the business has become.

4. Recommendations

Because the company is in the process of being struck off, traditional financial wellness recommendations do not apply. Instead, the focus must shift to end-of-life care and compliance:

  • Clear Remaining Debts: Ensure the remaining £2,773 in current liabilities is fully settled before the company is officially dissolved. If a company is struck off while still owing money, creditors can apply to the court to have it restored to the register, which is costly and time-consuming.
  • Asset Distribution: The remaining net assets of £784 belong to the shareholders. The director must ensure these are properly distributed before dissolution. If assets remain at the time of strike-off, they will legally belong to the Crown as bona vacantia (ownerless property).
  • Withdraw the Strike-Off (If Trading Continues): If the intention was never to close the company, the director must immediately withdraw the strike-off application and file the necessary confirmation statements to keep the company active. However, given the financial trajectory, closure appears to be the intended course.
  • Record Keeping: The director must retain the company's financial and legal records for seven years after the date of dissolution, as required by UK law, to protect against any future retrospective "diagnoses" or claims from HMRC or other creditors.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 26 August 2026